ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2406

Machine Learning-Based Artificial Intelligence in Systemic Lupus Erythematosus: A Systematic Review of Outcome Prediction and Patient Stratification

Jorge Juan Fragío Gil1, Roxana González Mazario2, Pablo Martínez Calabuig3, Laura Salvador Maicas4, Mireia Sanmartin Martínez4, Iván Jesús Lorente Betanzos4, Amalia Rueda Cid4, Juan José Lerma Garrido4, Isabel Martínez Cordellat4 and Cristina Campos Fernández5, 1Hospital General Universitario, Valencia, Spain, 2Hospital General de Valencia, Valencia, Spain, 3Hospital General Universitario de Valencia, Spain/ Uversidad Catolica de Valencia San Vicente Martir, Valencia, Spain, Ontinyent, Spain, 4Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain, 5Hospital General de Valencia, Valencia

Meeting: ACR Convergence 2025

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systematic lupus erythematosus (SLE) is an autoimmune disease with prognostic challenges due to its cyclic diversity. Artificial intelligence and machine learning (ML) has emerged as a powerful tool for analyzing multifactorial SLE data. This systematic review aims to investigate the current use of ML in predicting clinical outcomes and stratifying SLE patients.

Methods: A comprehensive search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted for studies published up to May 2025 evaluating the use of machine learning for stratifying SLE patients and determining prognosis. Extracted data included study design, country, recruitment period, sample size, ML application and algorithms, study aims, inclusion criteria, and main results.

Results: Seventeen studies applying machine learning to 16,483 SLE patients were included, with 81% of participants being female. The majority of studies (58.8%) originated from the USA. Random Forest was the most frequently used algorithm (41.1%), followed by recurrent neural networks and support vector machines. Main applications included predicting disease activity/flares, lupus nephritis, hospitalization risk, and molecular subtypes. Model performance, assessed by area under the ROC curve in nine studies, ranged from 0.595 to 0.9375. Sensitivity and specificity, reported in three studies, ranged from 0.75 to 82.1 and 0.75 to 89.6, respectively.

Conclusion: Machine learning demonstrates strong performance in analyzing complex SLE datasets, enabling accurate prediction of prognosis, disease activity, hospitalization risk, and treatment response. These models consistently outperform traditional approaches, supporting more personalized care and clinical decision-making for SLE patients across diverse clinical scenarios.


Disclosures: J. Fragío Gil: Quibim, 1; R. González Mazario: None; P. Martínez Calabuig: None; L. Salvador Maicas: None; M. Sanmartin Martínez: None; I. Lorente Betanzos: None; A. Rueda Cid: None; J. Lerma Garrido: None; I. Martínez Cordellat: None; C. Campos Fernández: None.

To cite this abstract in AMA style:

Fragío Gil J, González Mazario R, Martínez Calabuig P, Salvador Maicas L, Sanmartin Martínez M, Lorente Betanzos I, Rueda Cid A, Lerma Garrido J, Martínez Cordellat I, Campos Fernández C. Machine Learning-Based Artificial Intelligence in Systemic Lupus Erythematosus: A Systematic Review of Outcome Prediction and Patient Stratification [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/machine-learning-based-artificial-intelligence-in-systemic-lupus-erythematosus-a-systematic-review-of-outcome-prediction-and-patient-stratification/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/machine-learning-based-artificial-intelligence-in-systemic-lupus-erythematosus-a-systematic-review-of-outcome-prediction-and-patient-stratification/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology